“My practice has changed greatly,” states Paul M. Karpecki, OD, FAAO, while speaking about emerging technologies in the treatment of dry eye during a 2015 reception hosted by Paragon BioTeck, Inc.
Awareness of punctal occlusion as a treatment option is growing among eye care professionals seeking to address the symptoms of dry eye disease (DED).
PORTLAND, Ore. — Paragon BioTeck, Inc., a privately held biopharmaceutical and medical device company specializing in the development of ophthalmic...
PORTLAND, Ore. — Paragon BioTeck, Inc., a privately held biopharmaceutical and medical device company specializing in the development of ophthalmic pharmaceuticals,...
© 2017 Paragon BioTeck, Inc. All Rights Reserved. Privacy Policy | Return Policy | Terms of Use | Social Media Guidelines
|
